| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |